RT Journal Article
SR Electronic
T1 Curating and translating the evidence about SARS-CoV-2 and COVID-19 for frontline public health and clinical care: The Novel Coronavirus Research Compendium (NCRC)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.26.21255437
DO 10.1101/2021.04.26.21255437
A1 Andrew D. Redd
A1 Lauren Peetluk
A1 Brooke Jarrett
A1 Colleen Hanrahan
A1 Sheree Schwartz
A1 Amrita Rao
A1 Andrew Jaffe
A1 Carli Jones
A1 Chelsea Lutz
A1 Clif McKee
A1 Eshan Patel
A1 Greg Rosen
A1 Henri Garrison Desany
A1 Heather McKay
A1 John Muschelli
A1 Kayte Andersen
A1 Malen A. Link
A1 Nikolas Wada
A1 Prativa Baral
A1 Ruth Young
A1 Denali Boon
A1 M. Kate Grabowski
A1 Emily S. Gurley
A1 the NCRC Team
YR 2021
UL http://medrxiv.org/content/early/2021/04/27/2021.04.26.21255437.abstract
AB The public health crisis created by the SARS-CoV-2 pandemic has spurred a deluge of scientific research aimed at informing public health and medical response to the COVID-19 pandemic. However, those working in frontline public health and clinical care had insufficient time to parse the rapidly evolving evidence and use it for decision making. Academics in public health and medicine were well-placed to translate the evidence for use by frontline clinicians and public health practitioners. The Novel Coronavirus Research Compendium (NCRC), a group of >50 faculty and trainees, began in March 2020 with the goal to quickly triage and review the large volume of preprints and peer-reviewed publications on SARS-CoV-2 and COVID-19, and to summarize the most important, novel evidence to inform pandemic response. From April 6, 2020 through January 1, 2021, 54,192 papers and preprints were screened by NCRC teams and 527 were selected for review and uploaded to the NCRC website for public consumption. The majority of papers reviewed were peer-reviewed publications (n=395, 75%), published in 102 journals; 25% (n=132) of papers reviewed were of preprints. The NCRC is a successful model of how academics can support practitioners by translating scientific knowledge into action and help to build capacity among students for this work. This approach could be used for health problems beyond COVID-19, but the effort is resource intensive and may not be sustainable over the long term.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (ADR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are either publicly available or available upon request.